Inger Sandlie

7.3k total citations · 1 hit paper
131 papers, 5.5k citations indexed

About

Inger Sandlie is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Inger Sandlie has authored 131 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Radiology, Nuclear Medicine and Imaging, 74 papers in Molecular Biology and 61 papers in Immunology. Recurrent topics in Inger Sandlie's work include Monoclonal and Polyclonal Antibodies Research (100 papers), Glycosylation and Glycoproteins Research (48 papers) and T-cell and B-cell Immunology (31 papers). Inger Sandlie is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (100 papers), Glycosylation and Glycoproteins Research (48 papers) and T-cell and B-cell Immunology (31 papers). Inger Sandlie collaborates with scholars based in Norway, United States and United Kingdom. Inger Sandlie's co-authors include Jan Terje Andersen, Ole Henrik Brekke, Terje E. Michaelsen, Kine Marita Knudsen Sand, Bjarne Bogen, Malin Bern, Jeannette Nilsen, Geir Åge Løset, Stian Foss and Richard S. Blumberg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Inger Sandlie

131 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Neonatal Fc Receptor (FcRn): A Misnomer?

2019 297 citations Michał Pyzik, Kine Marita Knudsen Sand et al. profile →

Peers

Countries citing papers authored by Inger Sandlie

Since Specialization

Citations

This map shows the geographic impact of Inger Sandlie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Sandlie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Sandlie more than expected).

Fields of papers citing papers by Inger Sandlie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Sandlie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Sandlie. The network helps show where Inger Sandlie may publish in the future.

Co-authorship network of co-authors of Inger Sandlie

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Sandlie. A scholar is included among the top collaborators of Inger Sandlie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Sandlie. Inger Sandlie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life 2025 ·PNAS Nexus ·(unknown), (unknown), (unknown), Stian Foss, J.H. Marco Jansen, (unknown), Mitchell Evers, Jeannette Nilsen, Karli R. Reiding, J Damen, Renate Burger, Algirdas Grevys, Bjørn Dalhus, Thomas Valerius, Inger Sandlie, Jeanette H.W. Leusen, Jan Terje Andersen	3
2	Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress 2025 ·BioDrugs ·Torleif Tollefsrud Gjølberg, (unknown), (unknown), (unknown), Inger Sandlie, Jan Terje Andersen	3
3	A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery 2023 ·PNAS Nexus ·(unknown), (unknown), Anette Kolderup, Marina Vaysburd, (unknown), Donna L. Mallery, Even Fossum, (unknown), Anna Albecka, Aleksandr Ianevski, Denis E. Kainov, Karine Flem‐Karlsen, (unknown), (unknown), Torleif Tollefsrud Gjølberg, Morten C. Moe, Magnar Bjørås, Inger Sandlie, Leo C. James, Jan Terje Andersen	5
4	Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge 2022 ·Science Immunology ·Stian Foss, (unknown), Maria Bottermann, Ruth Watkinson, (unknown), (unknown), Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	20
5	Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life 2022 ·Communications Biology ·Torleif Tollefsrud Gjølberg, Rahel Frick, (unknown), Stian Foss, Algirdas Grevys, Lene S. Høydahl, Øystein Kalsnes Jørstad, Tilman Schlothauer, Inger Sandlie, Morten C. Moe, Jan Terje Andersen	14
6	Contribution of the ex vivo placental perfusion model in understanding transplacental immunoglobulin G transfer 2022 ·Placenta ·Kine Marita Knudsen Sand, Michael Gruber, Inger Sandlie, Line Mathiesen, Jan Terje Andersen, Christian Wadsack	4
7	A high-affinity human TCR-like antibody detects celiac disease gluten peptide–MHC complexes and inhibits T cell activation 2021 ·Science Immunology ·Rahel Frick, Lene S. Høydahl, Jan Petersen, M. Fleur du Pré, Shraddha Kumari, (unknown), (unknown), Jeliazko R. Jeliazkov, Kristin Støen Gunnarsen, (unknown), Erik Sebastian Vik, (unknown), Knut E. A. Lundin, Sheraz Yaqub, Jørgen Jahnsen, Jeffrey J. Gray, Jamie Rossjohn, Ludvig M. Sollid, Inger Sandlie, Geir Åge Løset	18
8	FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex–driven autoimmunity 2020 ·The Journal of Experimental Medicine ·Jonathan J. Hubbard, Michał Pyzik, Timo Räth, Lisa K. Kozicky, Kine Marita Knudsen Sand, Amit Gandhi, Algirdas Grevys, Stian Foss, (unknown), Jonathan N. Glickman, Edda Fiebiger, Derry C. Roopenian, Inger Sandlie, Jan Terje Andersen, Laura M. Sly, Kristi Baker, Richard S. Blumberg	34
9	Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease 2018 ·Gastroenterology ·Lene S. Høydahl, Lisa Richter, Rahel Frick, Omri Snir, Kristin Støen Gunnarsen, Ole J.B. Landsverk, Rasmus Iversen, Jeliazko R. Jeliazkov, Jeffrey J. Gray, Elin Bergseng, Stian Foss, Shuo‐Wang Qiao, Knut E. A. Lundin, Jørgen Jahnsen, Frode L. Jahnsen, Inger Sandlie, Ludvig M. Sollid, Geir Åge Løset	61
10	A TCRα framework–centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions 2017 ·JCI Insight ·Kristin Støen Gunnarsen, Lene S. Høydahl, Louise F. Risnes, Shiva Dahal‐Koirala, Ralf S. Neumann, Elin Bergseng, (unknown), Rahel Frick, M. Fleur du Pré, Bjørn Dalhus, Knut E. A. Lundin, Shuo‐Wang Qiao, Ludvig M. Sollid, Inger Sandlie, Geir Åge Løset	12
11	TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity 2016 ·The Journal of Immunology ·Stian Foss, Ruth Watkinson, Algirdas Grevys, (unknown), Malin Bern, Lene S. Høydahl, Bjørn Dalhus, Terje E. Michaelsen, Inger Sandlie, Leo C. James, Jan Terje Andersen	34
12	Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization 2015 ·Journal of Controlled Release ·Stian Foss, Algirdas Grevys, Kine Marita Knudsen Sand, Malin Bern, Patricia A. Blundell, Terje E. Michaelsen, Richard J. Pleass, Inger Sandlie, Jan Terje Andersen	23
13	A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance 2012 ·Protein Engineering Design and Selection ·Paul J. Yazaki, (unknown), Divya Channappa, Chi Wai Cheung, Desiree Crow, Junie Chea, Erasmus Poku, (unknown), Jan Terje Andersen, Inger Sandlie, Kelly Davis Orcutt, K. Dane Wittrup, John E. Shively, Andrew Raubitschek, David Colcher	29
14	Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8 ⁻ CD11b ⁺ dendritic cells 2011 ·Proceedings of the National Academy of Sciences ·Kristi Baker, Shuo‐Wang Qiao, Timothy Kuo, Victoria G. Aveson, Barbara Platzer, Jan Terje Andersen, Inger Sandlie, Zhangguo Chen, Colin de Haar, Wayne I. Lencer, Edda Fiebiger, Richard S. Blumberg	175
15	Identification of Residues in the Cμ4 Domain of Polymeric IgM Essential for Interaction with Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) 2008 ·The Journal of Immunology ·Ashfaq Ghumra, Jean‐Philippe Semblat, Richard S. McIntosh, Ahmed Raza, Ingunn B. Rasmussen, Ranveig Braathen, Finn–Eirik Johansen, Inger Sandlie, Patricia K. A. Mongini, J. Alexandra Rowe, Richard J. Pleass	53
16	The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH‐dependent binding to albumin 2006 ·European Journal of Immunology ·Jan Terje Andersen, (unknown), Inger Sandlie	94
17	Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells 2005 ·Journal of Immunological Methods ·Gøril Berntzen, Elin Lunde, (unknown), Jan Terje Andersen, (unknown), Inger Sandlie	69
18	Differential Segmental Flexibility and Reach Dictate the Antigen Binding Mode of Chimeric IgD and IgM: Implications for the Function of the B Cell Receptor 2004 ·The Journal of Immunology ·Geir Åge Løset, Kenneth H. Roux, Ping Zhu, Terje E. Michaelsen, Inger Sandlie	40
19	Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activationin vitro 2001 ·European Journal of Immunology ·(unknown), Concepción de Inés, (unknown), Björn Cochlovius, (unknown), Tove Olafsen, Inger Sandlie, Melvyn Little	12
20	The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fcγ receptors, but the heavy chains must be disulfide bonded 1993 ·European Journal of Immunology ·Audun Aase, Inger Sandlie, Lars Norderhaug, Ole Henrik Brekke, Terje E. Michaelsen	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact